Galderma Group AG Share Price

Equities

GALD

CH1335392721

Personal Products

Market Closed - Swiss Exchange 16:31:55 08/05/2024 BST 5-day change 1st Jan Change
71.09 CHF +0.75% Intraday chart for Galderma Group AG +3.78% 0.00%

Financials

Sales 2024 * 4.43B 4.02B 355B Sales 2025 * 4.96B 4.51B 397B Capitalization 18.65B 16.93B 1,493B
Net income 2024 * 218M 198M 17.45B Net income 2025 * 468M 425M 37.47B EV / Sales 2024 * 4.73 x
Net Debt 2024 * 2.31B 2.09B 185B Net Debt 2025 * 1.81B 1.64B 145B EV / Sales 2025 * 4.12 x
P/E ratio 2024 *
88.3 x
P/E ratio 2025 *
37.6 x
Employees -
Yield 2024 *
0.07%
Yield 2025 *
0.35%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.75%
1 week+3.78%
Current month+3.78%
1 month+11.25%
More quotes
1 week
68.09
Extreme 68.09
73.20
1 month
61.50
Extreme 61.5
73.20
Current year
60.00
Extreme 60
73.20
1 year
60.00
Extreme 60
73.20
3 years
60.00
Extreme 60
73.20
5 years
60.00
Extreme 60
73.20
10 years
60.00
Extreme 60
73.20
More quotes
Date Price Change Volume
08/05/24 71.09 +0.75% 290 617
07/05/24 70.56 +0.94% 166,154
06/05/24 69.9 +0.68% 141,550
03/05/24 69.43 +1.15% 147,821
02/05/24 68.64 +0.20% 277,884

Delayed Quote Swiss Exchange, May 08, 2024 at 04:31 pm

More quotes
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
78.27 USD
Average target price
84.45 USD
Spread / Average Target
+7.89%
Consensus

Annual profits - Rate of surprise